Related Experiment Videos
Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists
K D Burris1, S M Fausing, P B Molinoff
1CNS Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA.
Advances in Pharmacology (San Diego, Calif.)
|November 5, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Common to both academia and industry: the challenge of discovery. An interview with Perry Molinoff.
Molecular interventions·2004
PT-141: a melanocortin agonist for the treatment of sexual dysfunction.
Annals of the New York Academy of Sciences·2003
Regulation of levels of 5-HT2A receptor mRNA.
Annals of the New York Academy of Sciences·1999
T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.
Advances in pharmacology (San Diego, Calif.)·2026
Tracking therapeutic T cells in vivo.
Advances in pharmacology (San Diego, Calif.)·2026
In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.
Advances in pharmacology (San Diego, Calif.)·2026
Transient T cell therapies.
Advances in pharmacology (San Diego, Calif.)·2026
Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.
Advances in pharmacology (San Diego, Calif.)·2026
Engineering T cell metabolism to enhance therapeutic efficacy.
Advances in pharmacology (San Diego, Calif.)·2026